The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconate - PubMed (original) (raw)
Review
The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconate
S Fishbane et al. Semin Dial. 2000 Nov-Dec.
Abstract
Intravenous iron treatment is an important component of anemia therapy for patients on dialysis. Until recently iron dextran was the only parenteral form of iron available in the United States. This drug has been associated with occasional serious adverse reactions, including full-blown anaphylaxis. In 1999 the Food and Drug Administration approved a second form of iron for intravenous administration, sodium ferric gluconate in sucrose. It is expected that by the time of this publication, a third agent, iron saccharate will also be approved. In this review the comparative safety of these three agents is critically evaluated.
Similar articles
- Sodium ferric gluconate complex in the treatment of iron deficiency for patients on dialysis.
Fishbane S, Wagner J. Fishbane S, et al. Am J Kidney Dis. 2001 May;37(5):879-83. doi: 10.1016/s0272-6386(05)80001-0. Am J Kidney Dis. 2001. PMID: 11325667 Review. - Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis.
Pai AB, Boyd AV, McQuade CR, Harford A, Norenberg JP, Zager PG. Pai AB, et al. Pharmacotherapy. 2007 Mar;27(3):343-50. doi: 10.1592/phco.27.3.343. Pharmacotherapy. 2007. PMID: 17316146 Clinical Trial. - A Comparative Look at the Safety Profiles of Intravenous Iron Products Used in the Hemodialysis Population.
Coppol E, Shelly J, Cheng S, Kaakeh Y, Shepler B. Coppol E, et al. Ann Pharmacother. 2011 Feb;45(2):241-7. doi: 10.1345/aph.1P466. Ann Pharmacother. 2011. PMID: 21304025 Review. - Parenteral iron therapy options.
Silverstein SB, Rodgers GM. Silverstein SB, et al. Am J Hematol. 2004 May;76(1):74-8. doi: 10.1002/ajh.20056. Am J Hematol. 2004. PMID: 15114602 Review.
Cited by
- Intravenous ferric derisomaltose for the treatment of iron deficiency anemia.
Auerbach M, Henry D, DeLoughery TG. Auerbach M, et al. Am J Hematol. 2021 Jun 1;96(6):727-734. doi: 10.1002/ajh.26124. Epub 2021 Feb 26. Am J Hematol. 2021. PMID: 33580972 Free PMC article. Review. - Micronutrients Dietary Supplementation Advices for Celiac Patients on Long-Term Gluten-Free Diet with Good Compliance: A Review.
Rondanelli M, Faliva MA, Gasparri C, Peroni G, Naso M, Picciotto G, Riva A, Nichetti M, Infantino V, Alalwan TA, Perna S. Rondanelli M, et al. Medicina (Kaunas). 2019 Jul 3;55(7):337. doi: 10.3390/medicina55070337. Medicina (Kaunas). 2019. PMID: 31277328 Free PMC article. Review. - Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach.
Madeddu C, Gramignano G, Astara G, Demontis R, Sanna E, Atzeni V, Macciò A. Madeddu C, et al. Front Physiol. 2018 Sep 20;9:1294. doi: 10.3389/fphys.2018.01294. eCollection 2018. Front Physiol. 2018. PMID: 30294279 Free PMC article. Review. - Pharmaceutical stability of colloidal saccharated iron oxide injection in normal saline.
Hira D, Suzuki A, Kono Y, Shimokawa K, Matsuoka S, Hasumoto KY, Kawahara H, Onoue M, Fujita T, Okano T, Kakumoto M. Hira D, et al. J Pharm Health Care Sci. 2018 Jul 25;4:21. doi: 10.1186/s40780-018-0116-0. eCollection 2018. J Pharm Health Care Sci. 2018. PMID: 30062041 Free PMC article. - Effect of Intravenous Iron Supplementation on Acute Mountain Sickness: A Preliminary Randomized Controlled Study.
Ren X, Zhang Q, Wang H, Man C, Hong H, Chen L, Li T, Ye P. Ren X, et al. Med Sci Monit. 2015 Jul 15;21:2050-7. doi: 10.12659/MSM.891182. Med Sci Monit. 2015. PMID: 26175087 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical